Navidea Biopharmaceuticals
Patents, Design & Utilities

Last updated:

List of all Navidea Biopharmaceuticals patents 9 in total

Status Patent
Application
Utility: Dual Balloon Catheter and Related Methods for Treatment of Heart Failure External link
Filling date: 26 Sep 2025 Issue date: 30 Jun 2022
Grant
Utility: Compounds and compositions for treating leishmaniasis and methods of diagnosis and treating using same External link
Filling date: 26 Sep 2025 Issue date: 28 Jun 2022
Application
Utility: SYNTHESIS OF UNIFORMLY DEFINED MOLECULAR WEIGHT MANNOSYLATED DEXTRANS AND DERIVATIVES THEREOF External link
Filling date: 26 Sep 2025 Issue date: 13 Jan 2022
Application
Utility: COMPOUNDS AND METHODS FOR DIAGNOSIS AND TREATMENT OF VIRAL INFECTIONS External link
Filling date: 26 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: COMPOSITIONS AND RELATED METHODS FOR BLOCKING OFF-TARGET LOCALIZATION OF MANNOSYLATED DEXTRANS AND OTHER CD206 LIGANDS External link
Filling date: 26 Sep 2025 Issue date: 20 May 2021
Grant
Utility: Compounds and methods for diagnosis and treatment of viral infections External link
Filling date: 26 Sep 2025 Issue date: 18 May 2021
Application
Utility: COMPOSITIONS AND RELATED METHODS FOR THE ABLATION OF M2 MACROPHAGES AND MYELOID DERIVED SUPPRESSOR CELLS External link
Filling date: 26 Sep 2025 Issue date: 25 Feb 2021
Application
Utility: COMPOSITIONS AND METHODS FOR ALTERING MACROPHAGE PHENOTYPE External link
Filling date: 26 Sep 2025 Issue date: 1 Oct 2020
Application
Utility: COMPOSITIONS AND METHODS FOR ASSESSING MACROPHAGE MEDIATED PATHOLOGY External link
Filling date: 26 Sep 2025 Issue date: 30 Jul 2020

Showing 1 to 9 of 9 patents.